Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations and Comprehensive Loss

v3.3.0.814
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Revenues $ 1,851 $ 205
Operating expenses:    
Research and development (related party of $995 and $527) 3,495 1,898
Research and development - effect of Settlement Agreement (Note 8) 0 (1,041)
Research and development - effect of amendment to Collaboration and License Agreement (Note 8) 0 (1,007)
General and administrative 5,022 3,888
General and administrative - effect of Settlement Agreement (Note 8) 0 (700)
General and administrative - effect of amendment to Collaboration and License Agreement (Note 8) 0 1,007
Total operating expenses 8,517 4,045
Operating loss (6,666) (3,840)
Other income (expense):    
Interest income 9 8
Interest expense - effect of Settlement Agreement (Note 8) 0 122
Royalty income 32 42
Other income (expenses) 0 3
Loss on disposal of fixed assets 0 (1)
Total other income 41 174
Net loss (6,625) (3,666)
Comprehensive loss:    
Net loss (6,625) (3,666)
Other comprehensive loss-foreign currency translation adjustments (25) 0
Comprehensive loss $ (6,650) $ (3,666)
Loss per common share - basic and diluted (in dollars per share) $ (0.09) $ (0.06)
Weighted-average common shares outstanding - basic and diluted (in shares) 71,495 62,968